Compare Cadila Healthcare with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DISHMAN PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DISHMAN PHARMA CADILA HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 24.9 25.1 99.2% View Chart
P/BV x 4.4 3.3 130.3% View Chart
Dividend Yield % 0.8 0.7 119.1%  

Financials

 CADILA HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
DISHMAN PHARMA
Mar-16
CADILA HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs352374 94.1%   
Low Rs207129 160.2%   
Sales per share (Unadj.) Rs139.2197.8 70.4%  
Earnings per share (Unadj.) Rs11.821.2 55.5%  
Cash flow per share (Unadj.) Rs18.634.7 53.5%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %1.30.8 157.6%  
Book value per share (Unadj.) Rs101.4179.9 56.3%  
Shares outstanding (eoy) m1,023.7480.69 1,268.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.01.3 157.7%   
Avg P/E ratio x23.711.9 200.1%  
P/CF ratio (eoy) x15.07.2 207.6%  
Price / Book Value ratio x2.81.4 197.1%  
Dividend payout %29.89.4 315.4%   
Avg Mkt Cap Rs m286,03320,306 1,408.6%   
No. of employees `00013.40.8 1,617.0%   
Total wages/salary Rs m24,1455,355 450.9%   
Avg. sales/employee Rs Th10,632.719,252.7 55.2%   
Avg. wages/employee Rs Th1,801.26,459.5 27.9%   
Avg. net profit/employee Rs Th898.52,064.1 43.5%   
INCOME DATA
Net Sales Rs m142,53115,961 893.0%  
Other income Rs m1,139265 429.2%   
Total revenues Rs m143,67016,226 885.4%   
Gross profit Rs m24,1984,103 589.7%  
Depreciation Rs m6,9651,091 638.6%   
Interest Rs m3,418944 361.9%   
Profit before tax Rs m14,9542,334 640.8%   
Minority Interest Rs m2880-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198624 512.8%   
Profit after tax Rs m12,0441,711 703.9%  
Gross profit margin %17.025.7 66.0%  
Effective tax rate %21.426.7 80.0%   
Net profit margin %8.510.7 78.8%  
BALANCE SHEET DATA
Current assets Rs m87,15411,018 791.0%   
Current liabilities Rs m82,6949,517 868.9%   
Net working cap to sales %3.19.4 33.3%  
Current ratio x1.11.2 91.0%  
Inventory Days Days71110 64.6%  
Debtors Days Days9435 269.3%  
Net fixed assets Rs m133,23616,304 817.2%   
Share capital Rs m1,024161 634.4%   
"Free" reserves Rs m102,73312,907 796.0%   
Net worth Rs m103,75714,516 714.8%   
Long term debt Rs m32,1464,189 767.3%   
Total assets Rs m236,86629,805 794.7%  
Interest coverage x5.43.5 154.9%   
Debt to equity ratio x0.30.3 107.3%  
Sales to assets ratio x0.60.5 112.4%   
Return on assets %6.58.9 73.3%  
Return on equity %11.611.8 98.5%  
Return on capital %13.717.5 78.3%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m52,7524,952 1,065.4%   
Fx outflow Rs m14,504697 2,081.5%   
Net fx Rs m38,2484,255 899.0%   
CASH FLOW
From Operations Rs m25,0542,786 899.2%  
From Investments Rs m-10,123-1,529 662.1%  
From Financial Activity Rs m-10,942-941 1,162.7%  
Net Cashflow Rs m3,989316 1,260.7%  

Share Holding

Indian Promoters % 74.8 61.4 121.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 12.7 46.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 22.1 49.8%  
Shareholders   44,069 46,261 95.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   UNICHEM LAB  AUROBINDO PHARMA  STERLING BIOTECH  GLENMARK PHARMA  VENUS REMEDIES  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day lower.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading?(Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 5, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS